Plasma pyridoxal 5′-phosphate is not correlated with hemoglobin during pyridoxine supplementation in patients with rheumatoid arthritis

@article{Huang2011PlasmaP5,
  title={Plasma pyridoxal 5′-phosphate is not correlated with hemoglobin during pyridoxine supplementation in patients with rheumatoid arthritis},
  author={Y-C Huang and James Cheng-Chung Wei},
  journal={European Journal of Clinical Nutrition},
  year={2011},
  volume={65},
  pages={425-426}
}
After reviewing our recently published study (Huang et al., 2010), Cohick and Bhattacharjee (2011) suggest stopping the administration of pyridoxine once the hemoglobin level reaches a tolerable level (10–12 g/dl) to prevent a deleterious rise in ferritin levels. Although anemia is frequently associated with rheumatoid arthritis (RA) (Wilson et al., 2004), none of our patients had anemia; the short disease duration (2.6±1.6 years) of our patients may have not yet influenced their hematological… CONTINUE READING